Related references
Note: Only part of the references are listed.MEK1-RSK2 contributes to hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination
Z. Liu et al.
ONCOGENE (2014)
Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
June Y. Hou et al.
PLOS ONE (2013)
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond
Genevieve Deblois et al.
NATURE REVIEWS CANCER (2013)
Glucose-Regulated Protein 78 Controls Cross-talk between Apoptosis and Autophagy to Determine Antiestrogen Responsiveness
Katherine L. Cook et al.
CANCER RESEARCH (2012)
ERRs and cancers: Effects on metabolism and on proliferation and migration capacities
Stephanie Bianco et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Glucose Oxidation Modulates Anoikis and Tumor Metastasis
Sushama Kamarajugadda et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Biological mechanisms and clinical implications of endocrine resistance in breast cancer
Mario Giuliano et al.
BREAST (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Use of Standard Markers and Incorporation of Molecular Markers Into Breast Cancer Therapy Consensus Recommendations From an International Expert Panel
Manfred Kaufmann et al.
CANCER (2011)
The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer
Ching-yi Chang et al.
CANCER CELL (2011)
The Genomic Relationship Between Primary Breast Carcinomas and Their Nodal Metastases
Mohamed M. Desouki et al.
CANCER INVESTIGATION (2011)
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen
Sophie Lehn et al.
CELL CYCLE (2011)
Clinical significance of estrogen receptor phosphorylation
Leigh C. Murphy et al.
ENDOCRINE-RELATED CANCER (2011)
Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases
Yong Ren et al.
HUMAN MOLECULAR GENETICS (2011)
Estrogen-related receptor gamma modulates cell proliferation and estrogen signaling in breast cancer
Nobuhiro Ijichi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Estrogen related receptors (ERRs): A new dawn in transcriptional control of mitochondrial gene networks
Lillian J. Eichner et al.
MITOCHONDRION (2011)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
C. Davies et al.
LANCET (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
miR-378☆ Mediates Metabolic Shift in Breast Cancer Cells via the PGC-1β/ERRγ Transcriptional Pathway
Lillian J. Eichner et al.
CELL METABOLISM (2010)
Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response
Rebecca B. Riggins et al.
ENDOCRINE-RELATED CANCER (2010)
BCL2 and CASP8 regulation by NF-κB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells
Ruchi Nehra et al.
FASEB JOURNAL (2010)
Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells
Shiam-Peng Tay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor α as a Determinant of Breast Cancer Heterogeneity
Genevieve Deblois et al.
CANCER RESEARCH (2009)
Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation
Yong Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
Daniele Generali et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism
Hongxia Wang et al.
JOURNAL OF PATHOLOGY (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer
Rebecca B. Riggins et al.
CANCER RESEARCH (2008)
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Vincent Giguere
ENDOCRINE REVIEWS (2008)
Phosphorylation-dependent sumoylation regulates estrogen-related receptor-α and -γ transcriptional activity through a synergy control motif
Annie M. Tremblay et al.
MOLECULAR ENDOCRINOLOGY (2008)
Tamoxifen-stimulated growth of breast cancer due to p21 loss
Abde M. Abukhdeir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nurrl is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SH-SY5Y cells
Tao Zhang et al.
NEUROSCIENCE LETTERS (2007)
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Jesse S. Boehm et al.
CELL (2007)
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Emily E. Bosco et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Estrogen-related receptor α1 transcriptional activities are regulated in part via the ErbB2/HER2 signalling pathway
Eric A. Ariazi et al.
MOLECULAR CANCER RESEARCH (2007)
Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity
Sayaka Takayanagi et al.
TOXICOLOGY LETTERS (2006)
International Union of Pharmacology. LXVI. Orphan nuclear receptors
Gerard Benoit et al.
PHARMACOLOGICAL REVIEWS (2006)
Mechanisms of MAPK signalling specificity
L. Bardwell
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation
YK Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα:: a combination therapy potentially targeting hypoxic and dormant tumor cells
Å Kronblad et al.
ONCOGENE (2005)
Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo
CA Dimitri et al.
CURRENT BIOLOGY (2005)
Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (Faslodex, Fulvestrant)
KB Bouker et al.
CANCER RESEARCH (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Estrogen receptor phosphorylation
DA Lannigan
STEROIDS (2003)
Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1
M Desclozeaux et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Constitutive MEK/MAPK activation leads to p27Kip1 deregulation and antiestrogen resistance in human breast cancer cells
JCH Donovan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
